Cargando...
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...
Gardado en:
| Publicado en: | Drugs |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728290/ https://ncbi.nlm.nih.gov/pubmed/31347092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01165-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|